SCOPUS 정보 검색 플랫폼

Archives of Dermatology

Volumn 139, Issue 1, 2003, Pages 89-90

How frequently are drugs associated with the development or exacerbation of subacute cutaneous lupus?

(1) Callen, Jeffrey P a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTILIPEMIC AGENT; BETA INTERFERON; HYDROCHLOROTHIAZIDE; MINOCYCLINE;

ANTIBODY PRODUCTION; ANTIBODY TITER; CLINICAL FEATURE; DISEASE EXACERBATION; DRUG CHOICE; DRUG WITHDRAWAL; EDITORIAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; PHOTOSENSITIVITY; PRESCRIPTION; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; AUTOANTIGENS; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC;

EID: 0037231531 PISSN: 0003987X EISSN: None Source Type: Journal
DOI: 10.1001/archderm.139.1.89 Document Type: Editorial

Times cited : (13)

References (7)

1
- 0021887992
- Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy
- Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med. 1985;103:49-51.
- (1985) Ann Intern Med , vol.103 , pp. 49-51
- Reed, B.R.¹ Huff, J.C.² Jones, S.K.³ Orton, P.W.⁴ Lee, L.A.⁵ Norris, D.A.⁶

2
- 0023039383
- Subacute cutaneous lupus erythematosus: Clinical, serologic and immunogenetic studies of 49 patients seen in a non-referral setting
- Callen JP, Kulick KB, Stelzer G, Fowler JF. Subacute cutaneous lupus erythematosus: clinical, serologic and immunogenetic studies of 49 patients seen in a non-referral setting. J Am Acad Dermatol. 1986;15:1227-1237.
- (1986) J Am Acad Dermatol , vol.15 , pp. 1227-1237
- Callen, J.P.¹ Kulick, K.B.² Stelzer, G.³ Fowler, J.F.⁴

3
- 0023713961
- Subacute cutaneous lupus erythematosus: Clinical, serologic, immunogenetic and therapeutic considerations
- Callen JP, Klein J. Subacute cutaneous lupus erythematosus: clinical, serologic, immunogenetic and therapeutic considerations. Arthritis Rheum. 1988;31:1007-1013.
- (1988) Arthritis Rheum , vol.31 , pp. 1007-1013
- Callen, J.P.¹ Klein, J.²

4
- 0036716823
- Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus
- Black DR, Hornung CA, Schneider PD, Callen JP. Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch Dermatol. 2002;138:1175-1178.
- (2002) Arch Dermatol , vol.138 , pp. 1175-1178
- Black, D.R.¹ Hornung, C.A.² Schneider, P.D.³ Callen, J.P.⁴

5
- 0034855867
- Terbinafine-exacerbated/induced subacute cutaneous lupus erythematosus: A report of 5 patients
- Callen JP, Hughes AP, Kulp-Shorten CL. Terbinafine-exacerbated/induced subacute cutaneous lupus erythematosus: a report of 5 patients. Arch Dermatol. 2001;137:1196-1198.
- (2001) Arch Dermatol , vol.137 , pp. 1196-1198
- Callen, J.P.¹ Hughes, A.P.² Kulp-Shorten, C.L.³

6
- 0037231631
- Drug-induced Ro/SSA-positive cutaneous lupus erythematosus
- Srivastava M, Rencic A, Diglio G, et al. Drug-induced Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol. 2003;139:45-49.
- (2003) Arch Dermatol , vol.139 , pp. 45-49
- Srivastava, M.¹ Rencic, A.² Diglio, G.³

7
- 0037116836
- Drug-induced systemic lupus erythematosus associated with etanercept therapy
- Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet. 2002;359:579-580.
- (2002) Lancet , vol.359 , pp. 579-580
- Shakoor, N.¹ Michalska, M.² Harris, C.A.³ Block, J.A.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.